TC.NASDAQBIOTC.NASDAQBIOTC.NASDAQBIO

TC.NASDAQBIO

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪39.64 M‬ILS
Fund flows (1Y)
‪−113.87 M‬ILS
Dividend yield (indicated)
Discount/Premium to NAV
0.9%
Shares outstanding
‪271.03 K‬
Expense ratio
1.23%

About TC.NASDAQBIO


Issuer
Meitav Investment House Ltd.
Brand
Tachlit
Inception date
Nov 13, 2018
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Primary advisor
Meitav Mutual Funds Ltd.
ISIN
IL0011445264
The fund will be managed in a way that is expected to lead to the realization of its mission, achieving results derived from the rate of change in the tracking asset (see details of the tracking asset

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
Exchange listed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of October 31, 2024
Exposure type
Bonds, Cash & Other
Government
Cash
Bonds, Cash & Other100.00%
Government69.87%
Cash31.96%
ETF0.83%
Miscellaneous−2.67%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows